Viewing Study NCT00106834


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-03-01 @ 8:59 PM
Study NCT ID: NCT00106834
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2005-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
Sponsor: Centocor, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module